GW823296
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GW823296, covering 2010-10-15 to 2010-10-15. Get the full timeline:
Most recent: Clinical Trial Update: GW823296 Repeat Dose Study In Healthy Male And Female Subjects [Phase 1]